Cytokine payload conjugation
Bright Peak uses site-specific, ADC-like chemical conjugation to pair its chosen cytokine payloads with therapeutic antibodies at any development stage.
Source: LinkedIn company description · Retrieved October 13, 2026
Bright Peak Therapeutics is an international research-driven organization dedicated to discovering and developing therapies.
Bright Peak is developing a portfolio of cytokines with optimized biological properties. The cytokine portfolio is intended for cancer and autoimmune disease treatment.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Bright Peak uses site-specific, ADC-like chemical conjugation to pair its chosen cytokine payloads with therapeutic antibodies at any development stage.
Source: LinkedIn company description · Retrieved October 13, 2026
Bright Peak conjugates its cytokines to other cytokines to create duokines.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.